These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34488077)

  • 1. Sucrose subjective response and eating behaviors among individuals with opioid use disorder.
    Ochalek TA; Laurent J; Badger GJ; Sigmon SC
    Drug Alcohol Depend; 2021 Oct; 227():109017. PubMed ID: 34488077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweet taste pleasantness is modulated by morphine and naltrexone.
    Eikemo M; Løseth GE; Johnstone T; Gjerstad J; Willoch F; Leknes S
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3711-3723. PubMed ID: 27538675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM; Arnsten J; Olsen JP; Arias F; Cunningham CO; Rivera Mindt M
    Addict Sci Clin Pract; 2021 Oct; 16(1):64. PubMed ID: 34689841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedonic eating behaviors and food preferences associated with medication-assisted treatment for opioid use disorder.
    McDonald E; Laurent J
    J Opioid Manag; 2019; 15(6):487-494. PubMed ID: 31850510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
    Nayak SM; Huhn AS; Bergeria CL; Strain EC; Dunn KE
    Drug Alcohol Depend; 2021 Apr; 221():108649. PubMed ID: 33640679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study.
    Ochalek TA; Heil SH; Higgins ST; Badger GJ; Sigmon SC
    Drug Alcohol Depend; 2018 Sep; 190():224-228. PubMed ID: 30056321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial.
    Walsh SL; Comer SD; Lofwall MR; Vince B; Levy-Cooperman N; Kelsh D; Coe MA; Jones JD; Nuzzo PA; Tiberg F; Sheldon B; Kim S
    JAMA Psychiatry; 2017 Sep; 74(9):894-902. PubMed ID: 28655025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder.
    Pytell JD; Sklar MD; Carrese J; Rastegar DA; Gunn C; Chander G
    J Gen Intern Med; 2022 Feb; 37(3):593-600. PubMed ID: 34027611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undetected Respiratory Depression in People with Opioid Use Disorder.
    Tas B; Kalk NJ; Lozano-García M; Rafferty GF; Cho P; Kelleher M; Moxham J; Strang J; Jolley CJ
    Drug Alcohol Depend; 2022 May; 234():109401. PubMed ID: 35306391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the type of subjective response to first opioid exposure predict the risk of opioid use disorder? A scoping review.
    Morris CJ; Mills-Huffnagle S; Zgierska AE
    Brain Res Bull; 2022 Oct; 188():67-76. PubMed ID: 35901984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
    Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.
    Zhu Y; Mooney LJ; Yoo C; Evans EA; Kelleghan A; Saxon AJ; Curtis ME; Hser YI
    Drug Alcohol Depend; 2021 Nov; 228():108996. PubMed ID: 34555691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone.
    Mannelli P; Douaihy AB; Zavod A; Legedza A; Akerman SC; Sullivan MA
    Am J Drug Alcohol Abuse; 2021 Nov; 47(6):753-759. PubMed ID: 34752714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmedical use of gabapentin and opioid agonist medications in treatment-seeking individuals with opioid use disorder.
    Ellis MS; Buttram ME; Kasper ZA
    Drug Alcohol Depend; 2022 May; 234():109400. PubMed ID: 35290917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care.
    Smith K; Wang M; Abdukalikov R; McAullife A; Whitesell D; Richard J; Sauer W; Quaye A
    J Clin Pharmacol; 2022 Apr; 62(4):449-462. PubMed ID: 34775634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.